Category: Include on Menu
-
PTL Limited approves 1-for-80 share consolidation to maintain Nasdaq compliance
PTL Limited (NASDAQ:PTLE) said on February 24, 2026, that it has secured approval to implement a 1-for-80 consolidation of its Class A and Class B ordinary shares, a move aimed at restoring compliance with Nasdaq’s minimum bid price requirement and preserving its listing on the Nasdaq Capital Market. The Hong Kong-based marine fuel logistics company…
-
Palvella Therapeutics shares surge on positive Phase 3 trial results
Palvella Therapeutics (NASDAQ:PVLA) shares climbed about 15% on Tuesday after the company announced positive topline data from its Phase 3 SELVA clinical trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel for the treatment of microcystic lymphatic malformations (mLM). The late-stage study achieved its primary endpoint, demonstrating a statistically significant improvement on the Microcystic Lymphatic Malformation Investigator…
-
Shoals Technologies shares drop 11% after earnings miss offsets revenue growth
Shoals Technologies Group, Inc. (NASDAQ:SHLS) shares fell 11.21% in pre-market trading Tuesday after the company reported mixed fourth-quarter results, with weaker-than-expected earnings overshadowing a revenue beat and upbeat forward guidance. The electrical balance-of-system solutions provider posted adjusted earnings per share of $0.10, missing analyst forecasts of $0.13 for the quarter. Revenue, however, rose strongly, climbing…
-
Ideal Power shares slide after $14M equity raise announcement
Ideal Power Inc. (NASDAQ:IPWR) shares dropped 16.9% on Tuesday after the company unveiled plans for an underwritten public offering alongside a concurrent private placement expected to generate roughly $14.0 million in gross proceeds. The Austin, Texas–based semiconductor developer said it priced a public offering of 4,458,736 shares of common stock, or pre-funded warrants in lieu…
-
BioRestorative secures Australian patent protection for ThermoStem® obesity therapy platform
BioRestorative Therapies, Inc. (NASDAQ:BRTX) said Tuesday that Australia’s intellectual property authority has approved a key patent application covering its ThermoStem® technology, expanding global protection for the company’s stem cell–based treatment approach targeting obesity and metabolic disorders. The allowance, granted by IP Australia under Patent Application No. 2020265664, relates to “Non-naturally occurring three-dimensional (3D) brown adipose-derived…
-
Bargain buying may help Wall Street stage an early rebound: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures pointed to a modestly higher open on Tuesday, suggesting equities could recover some of the losses recorded in the previous session’s sharp sell-off. Investors may be drawn back into the market by lower valuations following Monday’s decline, which pushed the Dow to its weakest closing level in a month. Still, any…
-
Home Depot posts stronger-than-expected Q4 comparable sales growth
Home Depot (NYSE:HD) reported an unexpected rise in fourth-quarter comparable sales, signaling resilient U.S. demand even amid limited storm activity and an uncertain operating environment. The home-improvement retailer said same-store sales increased 0.4% during the period, outperforming Bloomberg consensus expectations that had called for a 0.36% decline. In the United States, comparable sales edged up…
-
Helix Energy Solutions shares rise 2% after earnings beat despite revenue shortfall
Helix Energy Solutions Group, Inc. (NYSE:HLX) reported fourth-quarter results on Tuesday that exceeded profit expectations but came in below revenue forecasts. The offshore energy services provider saw its shares gain 2.09% in premarket trading following the release. Adjusted earnings per share totaled $0.06 for the quarter, ahead of the analyst consensus estimate of $0.02. Revenue…
-
Amer Sports shares drop more than 7% after fourth-quarter earnings miss
Amer Sports, Inc. (NYSE:AS) reported fourth-quarter results on Tuesday that fell short of profit expectations, even as revenue exceeded forecasts, with increased investment spending weighing on margins. The company’s shares declined 7.38% in premarket trading following the announcement. Adjusted earnings per share came in at $0.31 for the quarter, below analyst estimates of $0.41. Revenue…
-
Clarivate shares climb over 3% after earnings beat and strong outlook
Clarivate Plc (NYSE:CLVT) reported fourth-quarter results on Tuesday that topped analyst expectations and issued fiscal 2026 guidance that came in ahead of consensus forecasts. Shares of the global intelligence company rose 3.57% in premarket trading following the announcement. Adjusted earnings per share for the fourth quarter totaled $0.21, surpassing analyst estimates of $0.16 by $0.05.…